Health Care > EXAM > Family Medicine Board Review Questions And Answers 100% solved and with Rationale (All)
Family Medicine Board Review Questions And Answers 100% solved and with Rationale A 42-year-old Asian male presents for follow-up of elevated blood pressure. He has no additional chronic medical pr... oblems and is otherwise asymptomatic. An examination is significant for a blood pressure of 162/95 mm Hg but is otherwise unremarkable. Laboratory Findings unremarkable Urine microalbumin negative According to the American College of Cardiology/American Heart Association 2017 guidelines, which one of the following would be the most appropriate medication to initiate at this time? A) Clonidine (Catapres), 0.1 mg twice daily B) Hydralazine, 25 mg three times daily C) Lisinopril/hydrochlorothiazide (Zestoretic), 10/12.5 mg daily D) Metoprolol tartrate (Lopressor), 25 mg twice daily E) Triamterene (Dyrenium), 50 mg daily {{Correct Ans- ANSWER: C Rationale This patient has hypertension and according to both JNC 8 and American College of Cardiology/American Heart Association 2017 guidelines, antihypertensive treatment should be initiated. For the general non-African-American population, monotherapy with an ACE inhibitor, an angiotensin receptor blocker, a calcium channel blocker, or a thiazide diuretic would be appropriate for initial management. It is also appropriate to initiate combination antihypertensive therapy as an initial management strategy, although patients should not take an ACE inhibitor and an angiotensin receptor blocker simultaneously. Studies have shown that blood pressure control is achieved faster with the initiation of combination therapy compared to monotherapy, without an increase in morbidity. Lisinopril/hydrochlorothiazide would be an appropriate choice in this patient. -Blockers, vasodilators, - blockers, and potassium-sparing diuretics are not recommended as initial choices for the treatment of hypertension. During rounds at the nursing home, you are informed that there are two residents on the unit with laboratory-confirmed influenza. According to CDC guidelines, who should receive chemoprophylaxis for influenza? A) Only symptomatic residents on the same unitB) Only symptomatic residents in the entire facility C) All asymptomatic residents on the same unit D) All residents of the facility regardless of symptoms E) All staff regardless of symptoms {{Correct Ans- ANSWER: C Rationale In long-term care facilities, an influenza outbreak is defined as two laboratory-confirmed cases of influenza within 72 hours in patients on the same unit. The CDC recommends chemoprophylaxis for all asymptomatic residents of the affected unit. Any resident exhibiting symptoms of influenza should be treated for influenza and not given chemoprophylaxis dosing. Chemoprophylaxis is not recommended for residents of other units unless there are two laboratory-confirmed cases in those units. Facility staff of the affected unit can be considered for chemoprophylaxis if they have not been vaccinated or if they had a recent vaccination, but chemoprophylaxis is not recommended for all staff in the entire facility [Show More]
Last updated: 2 years ago
Preview 1 out of 91 pages
Buy this document to get the full access instantly
Instant Download Access after purchase
Buy NowInstant download
We Accept:
Can't find what you want? Try our AI powered Search
Connected school, study & course
About the document
Uploaded On
Sep 16, 2022
Number of pages
91
Written in
This document has been written for:
Uploaded
Sep 16, 2022
Downloads
0
Views
63
In Scholarfriends, a student can earn by offering help to other student. Students can help other students with materials by upploading their notes and earn money.
We're available through e-mail, Twitter, Facebook, and live chat.
FAQ
Questions? Leave a message!
Copyright © Scholarfriends · High quality services·